Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Call for randomised clinical trials in EU for medtech is misplaced, says Eucomed head

This article was originally published in SRA

Executive Summary

A controversial report from the Belgian Health Care Knowledge Centre criticising the EU for failing when it comes to the pre-market demonstration of efficacy and safety of innovative, higher risk medical devices contains some significant misconceptions in the view of EU medtech industry association, Eucomed. Chief executive John Wilkinson explained to Amanda Maxwell his views on the premises adopted by the report's authors.

Advertisement
Advertisement
UsernamePublicRestriction

Register

MT039441

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel